Landmark’s Health Innovations 2023, a two-day virtual event held via Zoom, will bring together leaders in the intersecting worlds of Family Offices, HNW investors, pharma, and prominent device and therapeutic companies to explore the changing parameters and the latest innovative technologies transforming healthcare. The forum will feature virtual presentations from a roster of select companies seeking funding, an expert keynote address and panel discussion, and an informal "Investor Roundtable" panel to introduce a select number of Landmark’s Family Office and HNW investors.
A by-invitation event, registration is restricted to Landmark's investor members, Family Office members, and other invited guests. All registrations are subject to review. For more information, please contact email@example.com
Here is a list of NIH-funded companies attending this event.
Applying sophisticated technology platforms to revolutionize the way drugs are delivered to improve patient healthcare outcomes
|Liv Labs||A health tech startup building consumer-friendly solutions for urinary incontinence self-treatment||3/1|
|Oscillo Biosciences||An early-stage company whose mission is to awaken hope for all people living with Alzheimer's disease and related disorders||3/1|
|Regenosine||Harnessing the healing potential of adenosine for tissue regeneration||3/1|
|3 Helix (also an NIH Success Story)||Develops and markets a novel collagen-targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology||3/2|
|Applikate Technologies||A hardware and software company that has developed the first automated histology platform with integrated digital imaging||3/2|
|Opticyte||Transforming the standard of care for the leading causes of organ failure, including sepsis, with real-time measurement||3/2|